Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Winner

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Headache|January 18, 2006
Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescentsA David Rothner, Warren Wasiewski, Paul Winner, et al.
Pediatrics|August 3, 2007
Efficacy of zolmitriptan nasal spray in adolescent migraineDonald W Lewis, Paul Winner, Andrew D Hershey, et al.
Current Treatment Options in Neurology|February 10, 2007
Diagnosing and managing headache in childrenPaul Winner, Scott W Powers, Marielle A Kabbouche, et al.
Current Opinion in Pediatrics|November 21, 2007
HeadachesAndrew D Hershey, Paul Winner, Marielle A Kabbouche, et al.
Headache|February 27, 2003
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mgNinan T Mathew, Jean Schoenen, Paul Winner, et al.
Headache|February 24, 2006
Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute studyPaul Winner, A David Rothner, John D Wooten, et al.
Headache|December 17, 2002
Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT(1B/1D) agonist efficacy in migraineAnthony W Fox, Charlotte Keywood, Fred D Sheftell, et al.
Headache|May 15, 2002
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled studyPaul Winner, Donald Lewis, W Hester Visser, et al.
Headache|April 21, 2007
Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trialPaul Winner, Steven L Linder, Richard B Lipton, et al.
Headache|June 23, 2016
Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ)Paul Winner, Viktor Farkas, Helena Štillová, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Headache|January 18, 2006
Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescentsA David Rothner, Warren Wasiewski, Paul Winner, et al.
Pediatrics|August 3, 2007
Efficacy of zolmitriptan nasal spray in adolescent migraineDonald W Lewis, Paul Winner, Andrew D Hershey, et al.
Current Treatment Options in Neurology|February 10, 2007
Diagnosing and managing headache in childrenPaul Winner, Scott W Powers, Marielle A Kabbouche, et al.
Current Opinion in Pediatrics|November 21, 2007
HeadachesAndrew D Hershey, Paul Winner, Marielle A Kabbouche, et al.
Headache|February 27, 2003
Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mgNinan T Mathew, Jean Schoenen, Paul Winner, et al.
Headache|February 24, 2006
Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute studyPaul Winner, A David Rothner, John D Wooten, et al.
Headache|December 17, 2002
Comparison of therapeutic gain with therapeutic ratio for the assessment of selective 5HT(1B/1D) agonist efficacy in migraineAnthony W Fox, Charlotte Keywood, Fred D Sheftell, et al.
Headache|May 15, 2002
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled studyPaul Winner, Donald Lewis, W Hester Visser, et al.
Headache|April 21, 2007
Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trialPaul Winner, Steven L Linder, Richard B Lipton, et al.
Headache|June 23, 2016
Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ)Paul Winner, Viktor Farkas, Helena Štillová, et al.
Pageof 6